药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2015年
4期
407-409
,共3页
卞晓洁%杨靓靓%于冬悦%刘金永%葛卫红
卞曉潔%楊靚靚%于鼕悅%劉金永%葛衛紅
변효길%양정정%우동열%류금영%갈위홍
复方氨基酸注射液(20AA)%规范化%多重药学干预%处方合格率
複方氨基痠註射液(20AA)%規範化%多重藥學榦預%處方閤格率
복방안기산주사액(20AA)%규범화%다중약학간예%처방합격솔
Compound Amino Acid Injection (20AA)%Standardization%Multiple pharmacy interventions%Prescriptions pass rate
目的：明确复方氨基酸注射液（20AA）合理使用方法，提高含该制剂肠外营养处方合格率。方法：制定本院《20AA适用规范》，明确20AA仅适用于临床诊断为肝脏疾病或存在肝功能不全需使用静脉营养支持者；继而淘汰用量畸高厂家的品种，由临床药师对20AA用药进行干预。结果与结论：含20AA处方数占总肠外营养处方数由干预前的66.59%下降为22.29%，总超适应证不合格率由干预前的59.17%下降为33.33%，干预成功率由干预前的0%上升为10.3%。20AA的药学干预取得良好效果。
目的：明確複方氨基痠註射液（20AA）閤理使用方法，提高含該製劑腸外營養處方閤格率。方法：製定本院《20AA適用規範》，明確20AA僅適用于臨床診斷為肝髒疾病或存在肝功能不全需使用靜脈營養支持者；繼而淘汰用量畸高廠傢的品種，由臨床藥師對20AA用藥進行榦預。結果與結論：含20AA處方數佔總腸外營養處方數由榦預前的66.59%下降為22.29%，總超適應證不閤格率由榦預前的59.17%下降為33.33%，榦預成功率由榦預前的0%上升為10.3%。20AA的藥學榦預取得良好效果。
목적：명학복방안기산주사액（20AA）합리사용방법，제고함해제제장외영양처방합격솔。방법：제정본원《20AA괄용규범》，명학20AA부괄용우림상진단위간장질병혹존재간공능불전수사용정맥영양지지자；계이도태용량기고엄가적품충，유림상약사대20AA용약진행간예。결과여결론：함20AA처방수점총장외영양처방수유간예전적66.59%하강위22.29%，총초괄응증불합격솔유간예전적59.17%하강위33.33%，간예성공솔유간예전적0%상승위10.3%。20AA적약학간예취득량호효과。
Objective: To seek the rational practice of the compound amino acid preparation (20AA), and to improve the qualified rate of the parenteral nutritional prescriptions containing this preparation. Methods: A hospital "20AA applicable norms" was drafted demanding that 20AA should only be applied to intravenous nutritional support for clinically diagnosed liver disease or dysfunction. Then one extremely overprescribed 20AA product was sifted out, and all the prescriptions were continually intervened by clini-cal pharmacists. Results and conclusion: The 20AA prescriptions in the treatment of total parenteral nu-trition were decreased from 66.59% to 22.29%, the rate of overprescription was decreased from 59.17% to 33.33% after the intervention, and the success rate was raised from 0% to 10.3%. Rational use of 20AA was achieved by pharmaceutical intervention.
